血液恶性肿瘤患者应用PICC与植入式静脉输液港的效果比较

Comparison of the effects of PICC and venous access port in patients with hematological malignancies

目的比较经外周静脉穿刺中心静脉置管(PICC)与植入式静脉输液港(VAP)在血液恶性肿瘤患者化疗中的应用效果。方法选择血液恶性肿瘤患者62例,其中PICC组31例,VAP组31例,两组分别统计一次性置管成功率、导管留置时间和3个月、6个月及12个月导管相关并发症的发生率。结果 VAP组一次性置管成功率为87.1%,PICC组为93.5%(P>0.05);VAP组留置时间1年以上的患者为30例,PICC组为2例(P<0.05);两组并发症发生率,VAP组为6.4%,PICC组为29.0%(P<0.05)。结论 VAP是血液恶性肿瘤患者静脉输液的理想通路,在临床上值得推广。

Objective To compare the effects of peripherally inserted central catheters（PICC） and venous access port（VAP） in the chemotherapy in patients with hematological malignancies. Methods Totally 62 patients with hematological malignancies, were divided into two groups,30 cases with PICC and the other 30 cases with VAP. The one-time success rate of catheteriza- tion,duration of catheter indwelling,catheter-related eomplications at 3,6,and 12 months were compared between the two groups. Results The one-time success rate of catheterization was 87.1% in VAP group and 93.5% in PICC group,respectively （P〉0.05）. The catheters were retained for more than one year in 30 cases in VAP group and 2 cases in PICC group,respectively（P〈0.05）. The complications in VAP group was significantly lower than that of the PICC group（6.4% versus 29.0%,P〈0.05） Conclusion VAP is an ideal pathway for intravenous infusion of patients with hematological malignancies,which is worth to be promoted in clinical practice.